Asundexian: an Oral Small Molecule Factor Xia Inhibitor for the Treatment of Thrombotic Disorders
Future Cardiology · 2023-08 · 19 (10) · 477-486
DOI: 10.2217/fca-2023-0051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Cardiology, online erschienen am 13.10.2023. Verfasst von Nicasia D'Allesandro und 2 weiteren Autor:innen. Beteiligte Einrichtung: West Palm Beach Veterans Affairs Medical Center, 7305 N Military Trail, West Palm Beach, FL 33410, USA. Hauptthemen laut MEDLINE: Thrombosis, Atrial Fibrillation, Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West Palm Beach Veterans Affairs Medical Center, 7305 N Military Trail, West Palm Beach, FL 33410, USA.
ORCID-Profile: Nicasia D'Allesandro, Brandon Cave, Augustus Hough
Zitieren
APA
D'Allesandro, N., Cave, B., & Hough, A. (2023). Asundexian: an Oral Small Molecule Factor Xia Inhibitor for the Treatment of Thrombotic Disorders. Future Cardiology, 19(10), 477-486. https://doi.org/10.2217/fca-2023-0051
Vancouver
D'Allesandro N, Cave B, Hough A. Asundexian: an Oral Small Molecule Factor Xia Inhibitor for the Treatment of Thrombotic Disorders. Future Cardiology. 2023;19(10):477-486. doi:10.2217/fca-2023-0051
BibTeX
@article{DAllesandro2023,
author = {D'Allesandro, Nicasia and Cave, Brandon and Hough, Augustus},
title = {Asundexian: an Oral Small Molecule Factor Xia Inhibitor for the Treatment of Thrombotic Disorders},
journal = {Future Cardiology},
year = {2023},
volume = {19},
number = {10},
pages = {477--486},
doi = {10.2217/fca-2023-0051}
}
EUVIMED